Onco360, one of the nation’s largest independent providers of oncology pharmacy services, on Monday announced that Paul Jardina was named president and CEO.
Onco360, an independent oncology pharmacy and clinical support services company, announced that it has been selected to be part of the highly limited specialty pharmacy network of Zydelig tablets.
Cancer-focused specialty pharmacy Onco360 has signed a contract with privately owned pharmacy benefit manager MedImpact Healthcare Systems, whereby the pharmacy will offer its services to the PBM's members.
Inc. magazine released its annual Inc. 5000 list of top companies and for the second straight year, Onco360 has been named one of the fastest growing companies in America, the company stated.
Onco360 is joining the limited-distribution network for two newly approved cancer drugs made by GlaxoSmithKline, the specialty pharmacy company said.
The National Association of Specialty Pharmacy has appointed the leader of a cancer-focused specialty pharmacy to its board of directors.